Abstract

There is considerable evidence from our lab and others for a functional link between β-adrenergic receptor and insulin receptor signaling pathways in retina. Furthermore, we hypothesize that this link may contribute to lesions similar to diabetic retinopathy in that the loss of adrenergic input observed in diabetic retinopathy may disrupt normal anti-apoptotic insulin signaling, leading to retinal cell death. Our studies included assessment of neural retina function (ERG), vascular degeneration, and Müller glial cells (which express only β1 and β2-adrenergic receptor subtypes). In the current study, we produced β2-adrenergic receptor knockout mice to examine this deletion on retinal neurons and vasculature, and to identify specific pathways through which β2-adrenergic receptor modulates insulin signaling. As predicted from our hypothesis, β2-adrenergic receptor knockout mice display certain features similar to diabetic retinopathy. In addition, loss of β2-adrenergic input resulted in an increase in TNFα, a key inhibitor of insulin receptor signaling. Increased TNFα may be associated with insulin-dependent production of the anti-apoptotic factor, Akt. Since the effects occurred in vivo under normal glucose conditions, we postulate that aspects of the diabetic retinopathy phenotype might be triggered by loss of β2-adrenergic receptor signaling.

Highlights

  • Diabetic retinopathy is recognized as the leading cause of blindness in working age adults, we have yet to define the cellular mechanisms responsible for diabetes-induced loss of retinal neurons

  • In retinal Muller cells, we reported that insulin receptor signaling was altered when cells were grown in high glucose, which led to increased apoptosis that was prevented when Muller cells were treated with the b2adrenergic receptor agonist, salmeterol [11]

  • A major finding from these studies is that b2-adrenergic receptor knockout mice display neuronal and functional markers similar to those observed in diabetic mice, despite the presence of normal levels of glucose

Read more

Summary

Introduction

Diabetic retinopathy is recognized as the leading cause of blindness in working age adults, we have yet to define the cellular mechanisms responsible for diabetes-induced loss of retinal neurons. We showed that treatment with adrenergic receptor antagonists, in particular b-adrenergic receptor antagonists, caused a similar diabetic phenotype in retina [4,5]. These results led us to hypothesize that restoration of b-adrenergic signaling in diabetic retina might prevent or reduce retinal damage due to diabetes. To test this hypothesis, we treated streptozotocin-induced diabetic rats with a general b-adrenergic receptor agonist. The treatment prevented retinal damage in this model system. [6,7]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.